Etripamil Nasal Spray: A New At-Home Treatment for PSVT

March 2026

Rx etripamil (Cardamyst) will be the first nasal spray for home treatment of paroxysmal supraventricular tachycardia (PSVT).

This arrhythmia leads to over 200,000 ED visits each year.

Etripamil is a fast-acting nondihydropyridine calcium channel blocker that’s structurally similar to verapamil.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote